Form 4: Precigen Director Steven Frank Reports Acquisition and Disposal of Common Stock and Restricted Stock Units
SEC Form 4 Filing
Director Steven Frank reports transactions involving Precigen, Inc. common stock and restricted stock units, including acquisitions, disposals, and vesting of RSUs.
Summary
- On March 13, 2025, Director Steven Frank acquired 28,735 shares of Precigen, Inc. common stock at $1.74 per share in lieu of an annual retainer.
- On the same day, Frank acquired 71,839 restricted stock units (RSUs) that vest in full on March 13, 2026.
- Also on March 13, 2025, Frank acquired an option to purchase 83,517 shares of common stock at $1.74, exercisable from March 13, 2025, to March 13, 2035.
- On March 14, 2025, 87,412 RSUs vested in full.
- Following these transactions, Frank beneficially owns 1,140,307 shares of common stock and no RSUs.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of insider transactions. The acquisition of shares and RSUs could be interpreted slightly positively, but it's primarily informational.
Positives
- The acquisition of shares and RSUs by a director could be seen as a positive sign of confidence in the company's future.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash, stock, and stock options to align their interests with those of shareholders.
- The vesting schedules for RSUs are typical, often spanning one to several years to incentivize long-term commitment.
- Stock option grants are also a common component of executive compensation, providing an opportunity to benefit from future stock price appreciation.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's perspective on the company's value.
- The transactions have a minor impact on the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Acquisition of common stock and RSUs; grant of stock options. |
| 03/13/2026 | Vesting date for 71,839 RSUs. |
| 03/13/2035 | Expiration date for stock options. |
| 03/14/2025 | Vesting date for 87,412 RSUs. |
| 03/17/2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.